Use these selected concepts to connect clinical findings with diagnostic distinctions, safety boundaries and treatment-planning decisions for the American Board of Oral and Maxillofacial Surgery (ABOMS) Qualifying Examination. Each concept includes a resolved example and a specific mistake to avoid. Read the supporting references alongside the complete official examination blueprint.
Medical conditions and oral manifestations
1. Persistent dry mouth requires a cause-directed history
Persistent dry mouth should prompt review of medical conditions and medications, since NIDCR lists diabetes and several medication classes as possible causes, and dry mouth is not a normal part of aging; age alone is not an adequate explanation.
Worked example: An older adult reporting persistent dry mouth while taking bladder-control medication undergoes a medical and medication history review before age is accepted as the explanation.
Mistake to avoid: Attributing a patient's persistent dry mouth to age without reviewing medications or medical conditions.
Reference: [11]
2. Combined oral and ocular dryness suggests an autoimmune differential
Dry mouth with dry eyes and intermittent salivary enlargement supports considering Sjögren's syndrome; the Iowa protocol describes diagnosis using minor salivary gland biopsy with autoantibody testing, but the symptom combination alone is not a confirmed diagnosis.
Worked example: A patient with recurrent unilateral gland swelling, dry mouth, and dry eyes is considered for autoimmune assessment, including minor salivary gland biopsy and autoantibody testing, rather than assumed to have repeated stones.
Mistake to avoid: Treating recurrent gland swelling with sicca symptoms as repeated stones without autoimmune assessment.
Reference: [8]
3. Medical risk assessment remains relevant to an infected fracture
AO lists diabetes, immune deficiency, chronic corticosteroid medication, and osteopathy among medical risk factors in patients with infected mandibular fractures, so assessment extends beyond the fracture site to the patient's general health condition.
Worked example: A patient with an infected mandibular fracture, diabetes, and chronic corticosteroid exposure has medical risk factors reviewed alongside fixation assessment, without any glucose target or corticosteroid adjustment being specified.
Mistake to avoid: Reviewing only fixation in an infected fracture while omitting diabetes and chronic corticosteroid assessment.
Reference: [14]
4. Salivary dysfunction can arise from gland injury or nerve injury
NIDCR distinguishes damage to the salivary glands, such as radiation exposure during cancer treatment, from damage to the nerves that signal saliva production; mechanisms may differ between dry-mouth presentations.
Worked example: A patient with dry mouth after a head and neck injury is recognized as possibly having nerve-mediated salivary dysfunction, whereas a patient whose glands were exposed to cancer-treatment radiation may have direct gland damage.
Mistake to avoid: Assuming every dry-mouth presentation reflects the same anatomical mechanism without considering nerve versus gland injury.
Reference: [11]
5. Persistent xerostomia affects disease risk as well as comfort
Saliva moistens food, aids swallowing, and supplies minerals such as calcium and phosphate that keep teeth strong. When dryness persists, reduced saliva raises the risk of tooth decay and oral fungal infection, so persistent xerostomia matters for oral health beyond comfort.
Worked example: A patient with diabetes reports persistent dry mouth that feels tolerable; because lasting xerostomia can raise decay and fungal infection risk, the dentist assesses for oral complications rather than dismissing the mild subjective complaint.
Mistake to avoid: Treating a patient's tolerable dry-mouth complaint as proof that no decay or fungal risk exists.
Reference: [11]
Malignant hyperthermia principles
6. Trigger discontinuation during an acute crisis
During an acute malignant hyperthermia event, MHAUS advises notifying the surgeon to halt the procedure promptly and discontinuing volatile anesthetics and succinylcholine. If surgery must continue, general anesthesia is maintained with intravenous non-triggering anesthetics; lowering a volatile agent's dose is not discontinuation.
Worked example: During an acute malignant hyperthermia crisis, an anesthetist reduces the sevoflurane concentration instead of stopping it; MHAUS guidance requires discontinuing volatile agents and succinylcholine, with intravenous non-triggering anesthetics only if surgery must continue.
Mistake to avoid: Lowering the volatile anesthetic concentration during an acute MH event and calling it trigger discontinuation.
Reference: [4]
7. Dantrolene response has physiological indicators
MHAUS describes dantrolene response during an acute malignant hyperthermia event as a decrease in end-tidal carbon dioxide, decreased muscle rigidity, and/or lowered heart rate. Because the source uses and/or, improvement may appear in one indicator while another abnormality persists.
Worked example: After dantrolene, a patient's heart rate falls but muscle rigidity persists; the clinician records improvement in one response indicator while recognizing that rigidity, another listed indicator, remains abnormal rather than declaring the crisis resolved.
Mistake to avoid: Announcing full crisis resolution after dantrolene because only the end-tidal carbon dioxide has decreased.
Reference: [4]
8. Cooling depends on temperature and its trajectory
During an acute malignant hyperthermia event, MHAUS recommends cooling when core temperature exceeds 39°C, or at a lower temperature if temperature is rising rapidly, and stopping once temperature falls below 38°C. Rapid rise is an explicit exception to the numerical threshold.
Worked example: A patient's core temperature climbs rapidly from 38.2°C toward 38.7°C during an acute malignant hyperthermia event; although below 39°C, the rapid rise meets MHAUS's cooling condition, so cooling begins while trigger removal and dantrolene continue.
Mistake to avoid: Waiting for core temperature to exceed 39°C despite a rapidly rising temperature during an MH event.
Reference: [4]
9. Crisis monitoring extends beyond temperature
During an acute malignant hyperthermia event, MHAUS advises obtaining venous or arterial blood gases to determine the degree of metabolic acidosis and following heart rate, core temperature, ETCO2, minute ventilation, blood gases, potassium, creatine kinase, urine myoglobin and coagulation studies as warranted by the patient's clinical severity.
Worked example: During an acute MH event, an anesthesiologist reviews venous blood gases showing metabolic acidosis and tracks potassium and creatine kinase alongside temperature, adjusting the breadth of monitoring to the patient's clinical severity.
Mistake to avoid: Declaring the metabolic evaluation complete after documenting only a falling core temperature and heart rate.
Reference: [4]
10. Calcium channel blockers and calcium salts are different categories
In the cited acute MH protocol, MHAUS advises treating dysrhythmias with standard medication while avoiding calcium channel blockers, yet separately lists calcium chloride or calcium gluconate for life-threatening hyperkalemia. These are distinct drug categories, so the dysrhythmia warning does not prohibit every calcium-containing treatment.
Worked example: When a patient in an acute MH crisis develops life-threatening hyperkalemia, the team considers calcium chloride or calcium gluconate per protocol, while still avoiding calcium channel blockers for any dysrhythmias.
Mistake to avoid: Withholding calcium chloride from a hyperkalemic patient by confusing it with a calcium channel blocker.
Reference: [4]
11. Stabilization requires continued monitored care
MHAUS calls for transfer to a post-anesthesia care unit or intensive care unit for at least 24 hours once stable. Stability indicators—declining or normal ETCO2, stable or decreasing heart rate without ominous dysrhythmias, resolving hyperthermia, and resolved generalized muscular rigidity if present—must be considered together.
Worked example: After an acute MH event, a patient whose ETCO2 is normalizing but who still shows ominous dysrhythmias remains in the ICU, because the listed stability indicators must be considered together before the 24-hour observation period.
Mistake to avoid: Transferring a patient out of intensive care because the temperature alone has started resolving.
Reference: [4]
Dentoalveolar infection and soft-tissue care
12. Definitive dental treatment and systemic involvement
For symptomatic irreversible pulpitis, symptomatic apical periodontitis, or localized acute apical abscess in adults who are not severely immunocompromised, the 2019 ADA guideline prioritizes definitive dental treatment such as pulpotomy, pulpectomy, nonsurgical root canal treatment, or incision and drainage; antibiotics are indicated when systemic involvement, shown by fever or malaise, develops.
Worked example: An adult without severe immunocompromise presents with a localized acute apical abscess, no fever or malaise, and can receive incision and drainage immediately, so definitive dental treatment is prioritized over antibiotics.
Mistake to avoid: Prescribing antibiotics for a localized abscess without systemic signs although drainage is immediately available.
Reference: [5]
13. Impacted third molars can contribute to fracture-site infection
AO identifies impacted or partially impacted wisdom teeth as contributing factors in infected fractures of the posterior mandibular body or angle. A contributing factor is not a sole or inevitable cause, and no automatic extraction or removal technique is taught.
Worked example: A patient with an infected angle fracture adjacent to a partially impacted third molar prompts consideration of that local dental factor alongside fracture stability, without assuming the tooth's presence alone proves causation.
Mistake to avoid: Concluding that a partially impacted third molar near an infected angle fracture must automatically be extracted.
Reference: [14]
14. Intraoral wounds change postoperative hygiene needs
AO distinguishes patients with only extraoral approaches, who continue their daily hygiene schedule, from those with intraoral wounds, who require appropriate oral-hygiene instruction; arch bars and elastics make cleaning more difficult. No rinse formulation or appliance manipulation is prescribed.
Worked example: After mandibular fracture repair through an intraoral approach with arch bars and elastics, the surgeon assesses the patient's adapted hygiene needs rather than assuming the usual routine remains adequate.
Mistake to avoid: Giving identical postoperative hygiene instructions to every mandibular fracture patient regardless of wound location or appliances.
Reference: [6]
Mandibular fracture assessment and complications
15. Contamination and established fracture infection are different
AO considers dentate-region mandibular fractures open because they communicate with the oral cavity, and open fractures can generally be regarded as contaminated. Clinically relevant infection is a separate assessment involving findings such as swelling, pain, fever, redness or pus.
Worked example: A mandibular body fracture through the dentate region is classified as open and generally contaminated, yet without swelling, pain, fever, redness or pus, established infection is not thereby proven.
Mistake to avoid: Recording a contaminated dentate mandibular fracture as an established infection in the operative note.
Reference: [14]
16. Early imaging can be negative despite acute fracture infection
AO states radiographic signs can be absent in acute mandibular fracture infection, while chronic cases exhibit typical osteomyelitis changes. Clinical findings and imaging must therefore be interpreted together, and no universal imaging modality or sensitivity estimate is established.
Worked example: A patient with purulent drainage and facial inflammation one week after angle fracture repair has concerning clinical findings even when an early radiograph shows no destructive bone change.
Mistake to avoid: Discharging the patient because an early radiograph lacks destructive bone changes despite purulent drainage.
Reference: [14]
17. Fixation suitability changes with mandibular location
For simple mandibular body fractures, AO's guidance is location-dependent: a single load-sharing plate is contraindicated anteriorly, where rotational and torsional forces require two neutralizing miniplates; posteriorly, a second plate may be advantageous with reduced bone stock or significant displacement. Comminuted or atrophic fractures lie outside this reference's teaching scope.
Worked example: A candidate reviewing two simple body fractures declines copying a posterior single-plate plan to an anterior-body case, since anterior torsional forces require two miniplates, and notes this guidance covers neither comminuted nor atrophic fractures.
Mistake to avoid: Planning single-plate fixation for an anterior body fracture copied from a posterior case.
Reference: [6]
18. Reduction assessment combines occlusion and bony alignment
When confirming reduction intraoperatively in this mandibular fixation setting, AO recommends assessing occlusion and inspecting the exposed fracture line together, since a palpable step at the lower border indicates failed reduction; the two assessments are complementary, and no exposure or revision technique is prescribed.
Worked example: During closure after plating a simple body fracture, the surgeon notes satisfactory tooth contact but palpates a lower-border step, records the reduction as failed, and plans further assessment rather than accepting the occlusion alone.
Mistake to avoid: Declaring reduction successful after checking occlusion while ignoring a palpable lower-border bony step.
Reference: [6]
19. Fracture instability can sustain infection
For infected mandibular fractures with instability, AO states that fragment instability produces and maintains the infectious process, so antibiotic therapy alone does not eliminate the infection while the fracture remains unstable; antibiotics are not deemed unnecessary, and no stabilization or antimicrobial regimen is prescribed.
Worked example: A patient with an infected mandibular fracture shows documented fragment mobility; repeated antibiotic courses have not resolved the infection, and the team recognizes the unresolved instability as a sustaining factor rather than switching antimicrobials alone.
Mistake to avoid: Interpreting repeated antibiotic failure in an unstable infected fracture as needing only a different antimicrobial.
Reference: [14]
20. Postoperative malocclusion requires a cause
In postoperative mandibular fracture care, the malocclusion's cause requires clinical assessment with appropriate imaging: training elastics may benefit edema- or splinting-related malocclusion, but cannot correct bony problems from inadequate reduction or hardware failure, which need revision; no elastic force or revision procedure is specified.
Worked example: Weeks after mandibular fracture ORIF, imaging shows displaced hardware explaining a new bite discrepancy; the surgeon attributes the malocclusion to the bony problem rather than prescribing elastic training, which would not benefit this cause.
Mistake to avoid: Prescribing training elastics for malocclusion caused by hardware failure without first determining its etiology.
Reference: [6]
21. Tooth viability can deteriorate after fracture repair
Mandibular fracture lines close to dental roots may cause delayed loss of tooth vitality even after stable fixation and good early occlusion, so patients should continue routine dental follow-up, and periapical imaging is used to assess the teeth rather than the fixation.
Worked example: A patient's mandibular body fracture heals with a load-sharing miniplate, occlusion is stable at one week, yet the premolar beside the fracture line may still lose vitality later, so dental surveillance and periapical films continue.
Mistake to avoid: Discharging a patient from dental follow-up because the repaired fracture looks stable on early imaging.
Reference: [6]
Orthognathic diagnosis and planning
22. Orthognathic planning begins with a combined diagnosis
AO grounds orthognathic planning in a precise diagnosis that integrates clinical examination, cephalometry and standardized photography, while patient expectations and procedural risks also inform the plan; three-dimensional imaging may be indicated for complex asymmetric cases rather than being routine for every patient.
Worked example: Before planning a mandibular advancement, the surgeon records standardized photographs, obtains cephalometric analysis and reviews the patient's expectations and the procedure's risks; three-dimensional imaging may be indicated if the case involves complex asymmetry.
Mistake to avoid: Treating a single lateral cephalogram as sufficient diagnosis for a patient with marked facial asymmetry.
Reference: [12]
23. Profile and frontal assessment answer different questions
Profile evaluation records the anteroposterior positions of the maxilla and mandible, while frontal evaluation records facial midline, symmetry, lower lip and chin muscle activity, and tooth-to-lip relationships; the two views complement each other rather than replace one another.
Worked example: A patient shows a pleasing sagittal jaw relationship on profile view, yet frontal examination still reveals a deviated facial midline and asymmetric tooth-to-lip relationship, demonstrating that neither viewing plane alone completes the clinical assessment of the deformity.
Mistake to avoid: Concluding the facial assessment is complete after documenting only the anteroposterior jaw positions in profile.
Reference: [12]
24. Cephalometric findings depend on the analysis protocol
Cephalometry compares an individual's facial skeletal proportions with reference norms using reference points, lines and angles marked on the radiograph, but analysis protocols differ; reported values therefore depend on the protocol, and conventional skeletal analysis is not identical to three-dimensional analysis.
Worked example: Two clinics report different mandibular plane angles for the same patient because each used a different cephalometric protocol; before comparing the numbers, the surgeons check which reference points, lines and constructions each analysis employed.
Mistake to avoid: Interpreting a cephalometric angle as abnormal without first identifying which analysis protocol produced the number.
Reference: [12]
25. Diagnostic models and mock-surgery models serve different purposes
AO's mounted-model workflow uses two sets: one set documents and analyzes the preoperative situation, while the second set is repositioned for mock surgery. The planned jaw position is a combined decision that the surgeon and orthodontist must both agree upon.
Worked example: A resident keeps the original mounted casts untouched as the diagnostic record, then uses a duplicate set to simulate the planned maxillomandibular correction that the surgeon and orthodontist have jointly agreed upon.
Mistake to avoid: Repositioning the only mounted model set for mock surgery, destroying the documented preoperative occlusal baseline.
Reference: [12]
26. Intermediate and final splints represent different surgical stages
In AO's two-jaw workflow, two acrylic splints are fabricated: the intermediate splint positions the first osteotomized jaw against the stable jaw, and the final splint is used after the second jaw has been osteotomized. The distinction is the surgical stage each splint serves.
Worked example: For a planned two-jaw correction, the team fabricates an intermediate splint for the first osteotomized jaw against the stable jaw, plus a separate final splint for use after the second jaw's osteotomy.
Mistake to avoid: Bringing only the final occlusion splint to a two-jaw case, omitting the intermediate-stage splint.
Reference: [12]
27. Soft-tissue prediction is not a one-to-one translation
AO notes that when bone is moved, the overlying soft tissues follow, but not in a 1:1 ratio. Superimposed virtual images can therefore support discussing possible outcomes and alternatives with the patient, without guaranteeing any exact individual profile result.
Worked example: A plan shows a 5 mm mandibular skeletal advancement; the surgeon tells the patient the simulated image suggests approximate soft-tissue change but does not promise exactly 5 mm of lip movement.
Mistake to avoid: Telling the patient a 5 mm skeletal advancement guarantees exactly 5 mm of overlying soft-tissue change.
Reference: [12]
Facial filler selection and safety
28. Filler approval is specific to product, site and indication
FDA guidance dated July 2023 states dermal fillers are approved for adults 22 years or older for specific uses, and that approved indications vary by product. Glabellar, nasal, periorbital, forehead, and neck injection are identified as unapproved uses, not covered by general approval.
Worked example: A filler product approved in the United States for cheek augmentation in adults 22 or older is not thereby approved for nasal injection, because each product's labeling defines its own specific indications.
Mistake to avoid: Assuming one filler's FDA approval for cheek augmentation automatically covers nasal injection as well.
Reference: [15]
29. Allergy assessment must consider the actual filler ingredients
FDA notes that some dermal fillers contain lidocaine, animal-derived materials, collagen, egg products, or bacterial-fermentation hyaluronic acid. Suitability must be judged from the specific product's composition and labeling, not from its marketing name or general category.
Worked example: A patient reports a prior lidocaine reaction, so before an elective lip procedure the clinician reviews the specific filler's labeling and selects a product whose composition does not include lidocaine.
Mistake to avoid: Screening allergy suitability from the filler's brand name or category without checking its actual ingredient list.
Reference: [15]
30. Vascular complication signs require an immediate response
Unintended intravascular injection can block vessels and cause necrosis, vision abnormalities including blindness, or stroke. FDA advises stopping the injection immediately if blanching, vision change, stroke signs, or unusual pain occurs during or shortly after the procedure.
Worked example: Mid-cheek augmentation is paused when the patient develops unusual pain and skin blanching during injection, and the team arranges immediate appropriate medical care rather than observing the area briefly.
Mistake to avoid: Reassuring a patient with new vision changes during injection because vascular complications are statistically rare.
Reference: [15]
31. Active inflammation changes the timing of filler treatment
FDA advises that when an active inflammatory condition such as cysts, pimples, rashes, or hives, or an infection is present, dermal filler injection should be delayed until that inflammatory condition has been managed, regardless of an approved indication for the site.
Worked example: A patient requesting nasolabial fold correction has active hives near the intended injection site, so the clinician defers the elective filler visit until the inflammatory condition has been managed.
Mistake to avoid: Injecting filler into a site with an active rash because the product is approved for that anatomical area.
Reference: [15]
32. Filler persistence and removability are separate considerations
Some fillers are naturally absorbed over time, so effects may need repeating, while non-absorbable products persist. Removal may be difficult or impossible, especially for permanent fillers or materials other than hyaluronic acid, and removal procedures carry their own risks.
Worked example: A patient wanting long-lasting cheek correction is told that a permanent filler may be difficult or impossible to remove if the result is unwanted, since removal procedures carry their own risks.
Mistake to avoid: Promising that any unwanted filler result can simply be dissolved later, regardless of the material injected.
Reference: [15]
33. Needle-free delivery cannot inherit approval from the filler
FDA guidance states that needle-free devices are not approved for injecting dermal fillers and that their safety and effectiveness for this purpose are unknown. An approved filler does not transfer approval to the delivery device, so the combination remains unapproved regardless of less-invasive marketing.
Worked example: A clinician considers loading an FDA-approved hyaluronic acid lip filler into a needle-free injector, reasoning that the product itself is approved; FDA guidance still treats that delivery combination as unapproved and directs providers not to use it.
Mistake to avoid: Assuming an approved filler legitimizes needle-free delivery because the device seems less invasive.
Reference: [15]
Temporomandibular disorders and facial pain
34. TMD can involve joints, muscles and associated headaches
NIDCR describes three broad TMD categories: joint disorders including disc disorders, disorders of the masticatory muscles, and headaches associated with a TMD. A person may have one or more of these conditions at the same time, so muscle tenderness and a joint disorder can coexist and both warrant assessment.
Worked example: During examination a resident records both masseter tenderness on palpation and reproducible joint tenderness; because NIDCR's categories can coexist, both findings are documented and assessed rather than one being treated as excluding the other.
Mistake to avoid: Using TMJ interchangeably with TMD, implying the anatomical joint excludes muscular pain disorders.
Reference: [13]
35. Painless joint sounds do not establish a treatment indication
NIDCR states that clicking or popping sounds in the TMJs without pain are common, considered normal, and do not require treatment. Painful sounds, jaw locking, and limited movement are separate findings that need assessment. An isolated painless click alone does not justify an appliance or procedure.
Worked example: A patient reports occasional painless clicking when opening widely but has no pain, locking, or limited movement; the clinician explains the sound is considered normal and defers any appliance or interventional treatment.
Mistake to avoid: Fabricating an occlusal splint for an isolated painless click, treating noise alone as pathology.
Reference: [13]
36. Facial pain needs a differential diagnosis
NIDCR states there is no widely accepted standard test to diagnose TMDs, and pain in the mouth, jaw, or face may or may not be TMD-related. Assessment combines a detailed symptom history, examination, and potentially imaging, with other conditions ruled out before a TMD diagnosis.
Worked example: A patient reports pain near the ear; the clinician takes a detailed history, examines the head, neck, face, and jaw, and considers other conditions before considering TMD rather than labeling it by location.
Mistake to avoid: Ordering a CT scan and diagnosing TMD from jaw-area pain location alone.
Reference: [13]
37. Initial TMD care should preserve treatment options
NIDCR explains that many jaw joint and muscle problems are temporary, and evidence for numerous treatments is limited, so conservative care is recommended before interventions that permanently change the jaw joints, teeth, or bite, or involve surgery.
Worked example: A patient with recent, uncomplicated jaw muscle pain is advised to try soft foods, gentle self-care, and habit reduction first, rather than receiving immediate crowns or tooth grinding intended to treat the TMD itself.
Mistake to avoid: Recommending irreversible occlusal adjustment immediately for a first, uncomplicated TMD pain presentation.
Reference: [13]
38. An intraoral appliance needs both a purpose and a safety boundary
NIDCR notes there is not a lot of evidence on whether intraoral appliances improve TMD pain, advises ensuring an appliance is not designed to permanently change the bite, and recommends stopping use and consulting a dentist or doctor if it causes pain.
Worked example: A patient wearing a nightguard to reduce jaw clenching develops new pain after several nights; the appliance use is stopped and the prescribing dentist is consulted rather than the patient persisting with wear.
Mistake to avoid: Telling a patient to keep wearing a painful new splint without reassessment.
Reference: [13]
39. Open TMJ surgery requires a specific indication and uncertainty discussion
NIDCR states open surgery makes permanent joint changes and has no long-term safety or effectiveness studies, so it should only be considered for joint destruction unfixable by other procedures or severe symptoms persisting despite other treatments.
Worked example: A patient with severe persistent pain and limited mouth opening despite prior conservative care and arthroscopy is referred for specialist assessment of possible open surgery, with its permanence and uncertain long-term evidence discussed.
Mistake to avoid: Offering open joint surgery for painless clicking as a routine preventive intervention.
Reference: [13]
Oral mucosal and salivary pathology
40. Leukoplakia is a clinical descriptive diagnosis
Leukoplakia is a diagnosis of exclusion: candidiasis, lichen planus, leukoedema, and similar conditions must be ruled out first. It is exclusively a clinical term with no specific histopathologic connotations, so the label alone establishes neither dysplasia nor invasion.
Worked example: A white palatal patch that resolves after antifungal treatment for candidiasis is never labeled leukoplakia, while a separate unexplained non-rubbing white patch still requires histological evaluation before any tissue-based conclusion is drawn.
Mistake to avoid: Recording leukoplakia on a report and treating it as confirmed dysplasia histologically.
Reference: [7]
41. Depth of invasion contributes to the primary tumor category
In the AJCC 8th edition oral cavity classification, depth of invasion is combined with tumor size to set the T category: a tumor of 2 cm or less with depth of invasion over 5 mm is T2, and depth of invasion is not tumor thickness.
Worked example: A 1.8 cm oral tongue tumor with 7 mm depth of invasion and no other staging findings is T2, because its depth exceeds the 5 mm T1 limit; this assigns only the T category.
Mistake to avoid: Staging a 1.8 cm tumor as T1 from surface size while ignoring its 7 mm depth of invasion.
Reference: [7]
42. Superficial gingival bone erosion does not establish T4
In AJCC 8th edition oral cavity staging, superficial bone or tooth-socket erosion by a gingival primary alone does not establish T4; T4a can reflect a tumor larger than 4 cm with depth of invasion exceeding 10 mm, or qualifying adjacent-structure invasion, and depth of invasion differs from tumor thickness.
Worked example: A gingival primary superficially eroding a tooth socket, without cortical invasion or another T4 criterion, is not T4a; a 4.5 cm tumor with 11 mm depth of invasion meets the size-and-depth criterion.
Mistake to avoid: Classifying a gingival cancer as T4a solely because it superficially erodes the tooth socket.
Reference: [7]
43. Histological confirmation and restaging answer different questions
Lip and oral cavity cancer must be confirmed histologically; inspection, palpation and diagnostic imaging assess disease extent for staging. When disease relapses, complete restaging is required to select appropriate additional therapy, so a recurrent lesion's current extent must be re-evaluated rather than assumed.
Worked example: A patient whose tongue cancer recurs keeps the original diagnosis and historical stage, but the recurrent disease undergoes complete restaging, using histological confirmation and imaging findings, to describe current extent and select appropriate additional therapy.
Mistake to avoid: Treating a CT scan as histological confirmation, or describing recurrent disease by its original stage.
Reference: [7]
44. Obstructive salivary disease includes stones and strictures
Obstructive sialadenitis can result from salivary stones or from ductal stenosis; calculi or strictures produce ductal dilation with pain and swelling during eating. Meal-related symptoms therefore support an obstructive differential without confirming a stone, since a stricture can produce the same pattern.
Worked example: A patient reports recurrent submandibular pain and swelling during meals, but imaging demonstrates no calculus; ductal stenosis remains in the differential, because strictures as well as stones can cause meal-related obstructive symptoms.
Mistake to avoid: Concluding that meal-related gland swelling proves a salivary stone when no calculus has been demonstrated.
Reference: [8]
45. Sialadenosis differs from inflammatory gland swelling
The Iowa protocol characterizes sialadenosis as chronic, bilateral, diffuse, painless gland enlargement that is non-inflammatory and non-neoplastic, and associates it with underlying metabolic or medical conditions, so this pattern warrants systemic assessment rather than automatic labeling as acute bacterial sialadenitis.
Worked example: A patient with long-standing symmetric parotid and submandibular swelling, no pain, and poorly controlled diabetes would prompt evaluation of the systemic condition rather than an automatic diagnosis of acute bacterial sialadenitis.
Mistake to avoid: Labeling every painless bilateral parotid swelling as acute suppurative sialadenitis and starting anti-staphylococcal treatment.
Reference: [8]
46. Neurological findings increase concern in a salivary mass
NCI notes that numbness or weakness from nerve involvement typically indicates malignancy in a salivary tumor, yet most parotid tumors, benign and malignant alike, present as asymptomatic masses, so a painless mass cannot be declared benign while new nerve weakness raises concern.
Worked example: A 62-year-old man has a two-month painless parotid mass with no facial symptoms; benign and malignant tumors both remain possible, but new lip weakness develops and increases concern for malignancy pending pathological diagnosis.
Mistake to avoid: Dismissing a firm parotid mass as benign simply because the patient reports no pain.
Reference: [10]
47. An infiltrative margin supports salivary tumor malignancy
NCI identifies demonstration of an infiltrative margin as the key guiding principle for establishing malignancy in a salivary gland tumor, while noting that differentiating benign from malignant tumors may be difficult.
Worked example: A palatal salivary lesion shows bland cytological features, but histopathological examination demonstrates tumor infiltrating beyond an ill-defined margin, so the growth interface, not cytological appearance alone, supports classifying it as malignant.
Mistake to avoid: Classifying a salivary tumor as benign from cytology while ignoring its infiltrative growth interface.
Reference: [10]
Defect reconstruction and recipient-site planning
48. A complete bony defect changes reconstruction requirements
AO describes debridement of an infected mandibular fracture as potentially leaving a bony defect for later repair, and states grafting becomes necessary when the defect extends throughout the entire fracture.
Worked example: After debridement of an infected mandibular body fracture, diseased bone removal leaves complete discontinuity across the whole fracture zone, so the full-thickness defect is planned for later grafting rather than managed like a limited residual defect.
Mistake to avoid: Treating a through-and-through post-debridement mandibular defect as equivalent to a limited residual bony gap.
Reference: [14]
49. Recipient-site planning must address oral communication
In AO's infected mandibular fracture reconstruction workflow, the intraoral mucoperiosteum is closed before any bone grafting, separating the defect from the oral cavity. Recipient-site planning must therefore resolve oral communication, not only bone volume, within this specified workflow rather than as a universal grafting rule.
Worked example: A surgeon planning reconstruction of an infected mandibular body defect outlines graft sizing and plate position but defers deciding how the intraoral soft tissue will be closed before grafting, omitting AO's stated requirement to separate the defect from the oral cavity first.
Mistake to avoid: Treating intraoral soft-tissue closure as an incidental detail rather than a required pre-grafting step.
Reference: [14]
50. Required graft quantity informs donor-site planning
In AO's infected mandibular fracture workflow, when immediate bone grafting is desired, bone is harvested from the anterior iliac crest or the tibial head according to surgeon preference and the amount of bone graft needed. Donor-site planning should reflect the required graft quantity; neither source is obligatory.
Worked example: For immediate grafting of an infected mandibular defect, the team estimates the graft volume needed and selects the anterior iliac crest or tibial head accordingly, rather than naming a donor site independently of the defect's requirements.
Mistake to avoid: Naming the iliac crest as the mandatory donor site regardless of the graft quantity required.
Reference: [14]
51. A small lower-gingival cancer defect may use a skin graft
For small stage II lower-gingival lesions, the cited PDQ section lists intraoral resection, with or without rim resection of bone, and repair with a split-thickness skin graft. This is a documented option in that specific setting, not a general graft-versus-flap selection algorithm for all oral cancer defects.
Worked example: A patient with a small stage II lower-gingival lesion undergoes intraoral resection, without rim bone resection, and the mucosal defect is repaired with a split-thickness skin graft, matching the PDQ-listed option for this specific small-lesion setting.
Mistake to avoid: Citing the split-thickness skin graft option as the required repair for every oral cancer resection defect.
Reference: [7]
52. Composite resection planning includes the resulting defect
For larger buccal mucosal cancers, the cited PDQ passage describes composite resection with reconstruction of the defect by pedicle flaps. A complete plan therefore addresses the resulting defect alongside the resection; this site-specific description does not establish pedicle flaps as a universal choice for every oral cancer defect.
Worked example: For a larger buccal mucosal cancer, the treatment plan documents the composite resection and, in the same plan, names pedicle-flap reconstruction of the resulting defect, since the PDQ description links the two components for this site and size.
Mistake to avoid: Documenting the composite resection while leaving reconstruction of the resulting buccal defect entirely unresolved.
Reference: [7]
Implant restoration and anatomical planning
53. The planned restoration guides implant assessment
The 2012 AAOMR position statement describes a shift from surgically driven to prosthetically driven implant therapy, so bone volume and adjacent anatomy are assessed in relation to the planned restoration's tooth position rather than in isolation. This planning principle does not itself guarantee restorative feasibility.
Worked example: A planning record shows abundant bone at an edentulous site, yet the planned tooth position for the intended restoration lies elsewhere; bone abundance alone does not establish that site as the suitable implant position.
Mistake to avoid: Selecting the implant site from bone measurements before defining the planned restoration's tooth position.
Reference: [16]
54. Posterior mandibular planning includes the lingual contour
The 2012 AAOMR statement identifies the inferior alveolar canal and the lingual concavity below the mylohyoid ridge as posterior mandibular structures whose variations can restrict implant placement, so assessment cannot be reduced to canal clearance alone.
Worked example: A cross-section shows ample vertical height above the inferior alveolar canal at a posterior mandibular site, but a pronounced lingual concavity beneath the mylohyoid ridge still can restrict placement, so suitability remains unresolved.
Mistake to avoid: Confirming canal clearance on one cross-section and declaring the posterior site suitable despite a lingual concavity.
Reference: [16]
55. The anterior mandible still contains vulnerable structures
The 2012 AAOMR statement calls the anterior mandible relatively safe but still requires identifying osseous and intraosseous neurovascular structures, including the lingual foramen, mandibular incisive canal, and anterior loop, before osteotomy and implant placement.
Worked example: An anterior mandibular site lies far from the posterior canal and is relatively safe, yet the lingual foramen, mandibular incisive canal, and anterior loop still require identification before any osteotomy is planned.
Mistake to avoid: Calling the anterior mandible risk-free because it lies away from the inferior alveolar canal.
Reference: [16]
56. Ridge deficiency affects the sequence of site development
The 2012 AAOMR statement distinguishes moderate horizontal and vertical deficiencies, which may be corrected with augmentation at osteotomy and fixture placement, from severe deficiencies requiring prior procedures such as ridge augmentation, with staging determined by individual clinical assessment.
Worked example: A severely resorbed site is scheduled like its moderately deficient neighbor for augmentation during fixture placement; the 2012 statement's distinction instead requires a prior ridge augmentation before implant placement at the severe site.
Mistake to avoid: Copying a simultaneous-augmentation plan from a moderately deficient site to a severely deficient ridge.
Reference: [16]
57. Postoperative implant imaging depends on symptoms
The 2012 AAOMR statement recommends intraoral periapical radiography for postoperative implant assessment when no clinical signs or symptoms are present, reserving immediate cross-sectional imaging for presentations such as implant mobility or altered sensation, especially in the posterior mandible. This reflects that statement's consensus guidance, not an independently verified current universal protocol, and altered sensation still requires clinical evaluation because imaging alone does not establish its cause or treatment.
Worked example: A patient reports new lower-lip numbness days after posterior mandibular implant placement, so cross-sectional imaging is considered; a different, symptom-free implant at routine review is assessed with periapical radiography instead.
Mistake to avoid: Ordering routine postoperative CBCT for an asymptomatic implant instead of periapical radiographs.
Reference: [16]
Imaging and digital surgical planning
58. CBCT spatial detail does not imply CT-equivalent soft-tissue contrast
The cited AAOMR statement notes that although CBCT images have high spatial resolution, scattered radiation adds noise, soft-tissue contrast is inferior to CT, and CBCT is not appropriate for detecting small radiodensity changes. In that document, CT refers to scanners using multirow detector arrays. This technical comparison makes no device-specific resolution or diagnostic-performance claim and does not treat CBCT as equivalent to conventional film radiography.
Worked example: A CBCT scan shows a crisp mandibular cortical outline, yet the clinician does not conclude the study can reliably detect small radiodensity changes, because the statement describes inferior soft-tissue contrast relative to CT.
Mistake to avoid: Assuming a sharply depicted bony contour proves reliable subtle soft-tissue characterization on CBCT.
Reference: [16]
59. Radiation optimization must preserve diagnostic adequacy
The 2012 AAOMR implant-imaging statement couples minimum radiation exposure with images of acceptable diagnostic quality: the protocol should use the smallest necessary and available field of view while extending beyond the immediate area of interest to include areas that could be affected by implant placement. Imaging must first be clinically justified, no numerical dose limit or acquisition setting is established, and every acquired CBCT volume requires appropriate interpretation, including abnormalities beyond the intended implant site.
Worked example: For a posterior maxillary implant, the clinician selects the smallest available field that includes the maxillary sinus needed to assess its relationship to the site, keeping image quality diagnostically acceptable rather than simply minimizing coverage.
Mistake to avoid: Cropping the scan so narrowly that a potentially affected adjacent structure is excluded from view.
Reference: [16]
60. Digital planning connects imaging data to a defined surgical relationship
The 2012 AAOMR statement describes exporting CT and CBCT volumetric datasets in DICOM format for import into third-party planning software, while AO's orthognathic workflow describes designing and printing virtual intermediate and final splints with CAD-CAM after a treatment plan is formulated from the clinical examination and skeletal problem list. These sources describe capabilities without validating every software package or printer, supply no software commands, device settings or surgical execution steps, and digital outputs depend on a clinically formulated plan.
Worked example: After importing a CBCT into planning software, the surgeon recognizes the file provides anatomical data only; the intended occlusion and splint relationships come from the clinical examination and formulated skeletal problem list.
Mistake to avoid: Treating DICOM file import and three-dimensional visualization as a completed surgical plan.
Sources
- ABOMS Qualifying Examination
- ABOMS 2027 Qualifying Examination Handbook
- ABOMS Qualifying Examination Blueprint
- MHAUS Managing a Crisis: Emergency Treatment for an Acute Malignant Hyperthermia Event
- ADA Antibiotics for Dental Pain and Swelling
- AO Surgery Reference: Simple Mandibular Body Fracture
- NCI Lip and Oral Cavity Cancer Treatment (PDQ)
- University of Iowa: salivary swelling, differential and management
- University of Iowa: sialendoscopy indications and contraindications
- NCI Salivary Gland Cancer Treatment PDQ, health professional version
- NIDCR Dry Mouth
- AO Surgery Reference: orthognathic surgery planning
- NIDCR Temporomandibular Disorders
- AO Surgery Reference: infected mandibular fractures and bone loss
- FDA Dermal Fillers: indications, contraindications and serious risks
- AAOMR Dental implant radiology selection position statement (2012; scope dated)